What are the treatment options for premenstrual syndromes (PMS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Premenstrual Syndrome (PMS)

For most women with PMS, a combination of lifestyle modifications and non-hormonal pharmacologic treatments should be the first-line approach, with selective serotonin reuptake inhibitors (SSRIs) being the most effective medication for moderate to severe symptoms. 1

Understanding PMS

Premenstrual syndrome (PMS) is characterized by recurrent physical, psychological, and behavioral symptoms that occur during the luteal phase of the menstrual cycle (typically 1-2 weeks before menstruation) and resolve within a few days of menstruation. PMS affects approximately 30-40% of reproductive-age women, with 3-8% experiencing a severe form called Premenstrual Dysphoric Disorder (PMDD) 2.

First-Line Treatment Options

Lifestyle Modifications

  • Diet changes: Reduce salt, fat, caffeine, and sugar intake 3
  • Regular aerobic exercise: Helps reduce symptom severity 3
  • Stress reduction techniques: Meditation, yoga, or other relaxation methods 3

Non-Hormonal Pharmacologic Treatments

NSAIDs

  • Ibuprofen: 400-800 mg every 6-8 hours during symptomatic days 4
  • Particularly effective for physical symptoms like cramping, headaches, and breast tenderness
  • Can be used for short-term treatment (5-7 days) during bleeding episodes 5

SSRIs (First-line medication for moderate to severe symptoms)

  • Fluoxetine: 20 mg daily 6, 1
  • Sertraline: 50-150 mg daily 1
  • Paroxetine: 10-30 mg daily 1
  • Escitalopram: 10-20 mg daily 1

SSRIs can be administered in two ways:

  1. Continuous administration: Daily throughout the menstrual cycle (more effective)
  2. Luteal phase administration: Only during the 2 weeks before menstruation 1

The Cochrane review found that continuous administration is probably more effective than luteal phase administration (P = 0.03 for subgroup difference) 1.

Second-Line Treatment Options

Hormonal Treatments

  • Combined oral contraceptives (COCs): May help with physical symptoms but less effective for mood symptoms 7
  • Continuous use of COCs: Some women with pure menstrual symptoms benefit from continuous use without a break 8
    • Note: COCs are contraindicated in women with migraine with aura due to increased stroke risk 8

Other Medications

  • Anxiolytics: For anxiety-predominant symptoms 7
  • Spironolactone: For bloating and fluid retention 7

Treatment Algorithm Based on Symptom Severity

Mild PMS

  1. Start with lifestyle modifications (diet, exercise, stress management)
  2. Add NSAIDs during symptomatic days if needed

Moderate PMS

  1. Lifestyle modifications
  2. NSAIDs for physical symptoms
  3. Consider SSRIs if symptoms impact quality of life

Severe PMS/PMDD

  1. SSRIs (continuous administration preferred)
  2. Lifestyle modifications as adjunctive therapy
  3. Consider hormonal treatments if SSRIs are ineffective

Common Side Effects of SSRIs

SSRIs are associated with several side effects, including:

  • Nausea (most common)
  • Insomnia
  • Sexual dysfunction
  • Fatigue
  • Dizziness
  • Dry mouth 1

Special Considerations

  • Women with migraine: Combined hormonal contraceptives are contraindicated in women with migraine with aura 8
  • Women approaching menopause: Higher risk of endometrial pathology; consider endometrial sampling 5
  • Women with depression: SSRIs may provide dual benefit for both PMS and depression 1

Monitoring and Follow-up

Evaluate treatment response within 2-3 months after initiation or change in treatment. Key outcome measures include symptom frequency, severity, and impact on daily functioning. Consider using a daily symptom diary to track effectiveness 8.

Cautions and Pitfalls

  • SSRIs may interact with other medications through CYP2D6 inhibition 6
  • Pure SSRIs (particularly paroxetine) should be used with caution in women taking tamoxifen due to potential drug interactions 8
  • When discontinuing SSRIs, gradually taper to minimize withdrawal symptoms 8
  • Recognize that PMS symptoms can overlap with other conditions like thyroid dysfunction, diabetes, and mood disorders 3

The evidence strongly supports that SSRIs are the most effective treatment for moderate to severe PMS/PMDD symptoms, particularly when administered continuously rather than only during the luteal phase 1.

References

Research

Premenstrual syndrome: diagnosis and intervention.

The Nurse practitioner, 1998

Guideline

Menometrorrhagia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.